Trial Profile

A Phase II Trial of Carboplatin, Bevacizumab and Pemetrexed in Advanced Non-Small Cell Lung Cancer.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 06 Apr 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pemetrexed (Primary) ; Bevacizumab; Carboplatin
Indications Non-small cell lung cancer
Focus Therapeutic Use

Most Recent Events

31 Mar 2017 Status changed from active, no longer recruiting to completed.
03 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jul 2017.
08 Jul 2016 Planned End Date changed from 1 Dec 2016 to 1 Jul 2017.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com